Nisa Investment Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$88K Sell
774
-16
-2% -$1.82K ﹤0.01% 1439
2025
Q1
$83.1K Sell
790
-3
-0.4% -$315 ﹤0.01% 1448
2024
Q4
$85K Buy
793
+35
+5% +$3.75K ﹤0.01% 1519
2024
Q3
$75.9K Buy
758
+2
+0.3% +$200 ﹤0.01% 1523
2024
Q2
$63.7K Buy
756
+15
+2% +$1.26K ﹤0.01% 1594
2024
Q1
$54.2K Buy
741
+15
+2% +$1.1K ﹤0.01% 1632
2023
Q4
$51.9K Buy
726
+10
+1% +$714 ﹤0.01% 1628
2023
Q3
$42.9K Sell
716
-8
-1% -$479 ﹤0.01% 1769
2023
Q2
$52.2K Buy
724
+60
+9% +$4.33K ﹤0.01% 1741
2023
Q1
$49K Hold
664
﹤0.01% 1725
2022
Q4
$44K Sell
664
-400
-38% -$26.5K ﹤0.01% 1819
2022
Q3
$58K Buy
1,064
+19
+2% +$1.04K ﹤0.01% 1692
2022
Q2
$58K Sell
1,045
-160
-13% -$8.88K ﹤0.01% 1683
2022
Q1
$85K Buy
1,205
+59
+5% +$4.16K ﹤0.01% 1677
2021
Q4
$89K Hold
1,146
﹤0.01% 1561
2021
Q3
$100 Hold
1,146
﹤0.01% 1703
2021
Q2
$94 Hold
1,146
﹤0.01% 1724
2021
Q1
$109 Buy
1,146
+320
+39% +$30 ﹤0.01% 1717
2020
Q4
$51K Sell
826
-961
-54% -$59.3K ﹤0.01% 1988
2020
Q3
$106K Buy
1,787
+865
+94% +$51.3K ﹤0.01% 1528
2020
Q2
$64K Sell
922
-1,531
-62% -$106K ﹤0.01% 1541
2020
Q1
$111K Buy
2,453
+433
+21% +$19.6K ﹤0.01% 1338
2019
Q4
$131K Buy
2,020
+321
+19% +$20.8K ﹤0.01% 1393
2019
Q3
$106K Buy
1,699
+1,539
+962% +$96K ﹤0.01% 1449
2019
Q2
$11K Hold
160
﹤0.01% 1732
2019
Q1
$13K Hold
160
﹤0.01% 1688
2018
Q4
$14K Sell
160
-12,412
-99% -$1.09M ﹤0.01% 1566
2018
Q3
$2.15M Buy
12,572
+12,332
+5,138% +$2.11M 0.02% 631
2018
Q2
$31K Buy
240
+80
+50% +$10.3K ﹤0.01% 1502
2018
Q1
$17K Sell
160
-80
-33% -$8.5K ﹤0.01% 1503
2017
Q4
$21K Hold
240
﹤0.01% 1537
2017
Q3
$20K Hold
240
﹤0.01% 1528
2017
Q2
$18K Hold
240
﹤0.01% 1518
2017
Q1
$16K Hold
240
﹤0.01% 1552
2016
Q4
$15K Sell
240
-401
-63% -$25.1K ﹤0.01% 1720
2016
Q3
$41K Hold
641
﹤0.01% 1427
2016
Q2
$48K Hold
641
﹤0.01% 1403
2016
Q1
$43K Buy
+641
New +$43K ﹤0.01% 1409